9
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
panel
FasterCures Roundtable (Invite only)
As health systems worldwide recover and rebuild in the retention wake of COVID-19, the importanc
e of early preparation, multi-stakeholder collaboration, and constant innovation must not be forgotten.
+ Read More
landing page
Research Partnership Maturity Model
FasterCures created the Research Partnership Maturity Model (RPMM) toolkit to enable patient organiz
ations that support or conduct research to 1) understand their assets and capab, Access the Model Visualization and Companion Guide
, Tools You Can Use
This collection of tools provides resources aligned to the RPMM domains, and examples that can support the growth of patient organizations hoping to build their capacity in
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
video
Advances in Science: Beyond “One Disease at a Time:” Therapeutic Platforms for Monogenic Disease
Guest speaker Philip John (P.J.) Brooks, PhD, acting director of the Division of Rare Diseases Res
earch Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) delivered a presentation about cell an
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically
article
Mapping the Patient and Caregiver Journey for Cell and Gene Therapies
Introduction
Advances in cell and gene therapies are transforming how we treat or potentially cure
disease. Cell and gene therapies aim to address the underlying cause of genetic and acquired diseases.
+ Read More
article
Comment Letter: Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Submitted electronically
The Honorable Diana DeGette
US House of Representatives
Washington, DC 205
15
The Honorable Fred Upton
US House of Representatives
Washington, DC 20515
+ Read More
article
Comment Letter: Office of Management and Budget (OMB) – Practices for Advancing Equity and Support for Underserved Communities
Submitted electronically
To: The Honorable Shalanda Young, Acting Director, Office of Management an
d Budget
From: Richard Ditizio, President and Chief Operating Officer, Milken Institute
+ Read More